2.42
3.85%
0.08
前日終値:
$2.34
開ける:
$2.36
24時間の取引高:
69,113
Relative Volume:
0.82
時価総額:
$287.54M
収益:
-
当期純損益:
$-63.68M
株価収益率:
-5.1489
EPS:
-0.47
ネットキャッシュフロー:
$-54.15M
1週間 パフォーマンス:
-1.22%
1か月 パフォーマンス:
-12.27%
6か月 パフォーマンス:
-12.27%
1年 パフォーマンス:
-10.00%
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
名前
Nautilus Biotechnology Inc
セクター
電話
206-333-2001
住所
2701 EASTLAKE AVE EAST, SEATTLE
NAUT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
NAUT | 2.43 | 287.54M | 0 | -63.68M | -54.15M | -0.47 |
VRTX | 448.89 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 746.20 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 597.08 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.44 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 108.14 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2022-01-06 | 開始されました | Morgan Stanley | Equal-Weight |
2021-11-02 | 開始されました | Cowen | Outperform |
2021-08-04 | 開始されました | Goldman | Neutral |
2021-07-13 | 開始されました | Jefferies | Buy |
Nautilus Biotechnology Inc (NAUT) 最新ニュース
Nautilus Biotechnology Reports Q3 2024 Financial Results - MSN
3 US Penny Stocks With Market Caps Up To $400M - Simply Wall St
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award - Quantisnow
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q3 2024 Earnings Call Transcript - Insider Monkey
Nautilus Biotechnology Co-founder and Chief Scientist Parag - GlobeNewswire
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award - Morningstar
Nautilus Biotechnology Faces ESG Challenges Amid Regulatory Pressure and Investor Scrutiny - TipRanks
Glass House Brands to Host Third Quarter 2024 Conference Call on November 13, 2024 - The Manila Times
Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference - GlobeNewswire
SG Americas Securities LLC Takes Position in Cardlytics, Inc. (NASDAQ:CDLX) - Defense World
Nautilus Biotechnology Reports Third Quarter 2024 Financial Results - GlobeNewswire
Nautilus Biotechnology reports Q3 EPS (13c), consensus (16c) - TipRanks
Nautilus Biotechnology (NAUT) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Renaissance Technologies LLC Decreases Stock Holdings in Immix Biopharma, Inc. (NASDAQ:IMMX) - Defense World
Renaissance Technologies LLC Acquires 9,459 Shares of Toro Corp. (NASDAQ:TORO) - Defense World
Renaissance Technologies LLC Has $358,000 Stock Holdings in Standard Lithium Ltd. (NYSE:SLI) - Defense World
Renaissance Technologies LLC Cuts Stock Holdings in OPKO Health, Inc. (NASDAQ:OPK) - Defense World
Nautilus Biotechnology Inc. - Scrip
We Think Nautilus Biotechnology (NASDAQ:NAUT) Can Afford To Drive Business Growth - Yahoo Finance
Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024 - The Manila Times
nautilus biotechnology, inc. Earnings dates - RTTNews
Clearline Capital LP Lowers Stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Tech Moves: GE healthcare exec joins startup; Nautilus taps new CMO; WRF investor steps down - MSN
Insider Selling: Nautilus Biotechnology, Inc. (NASDAQ:NAUT) VP Sells 47,031 Shares of Stock - Defense World
Nautilus Biotechnology senior VP sells over $134k in company stock - Investing.com
Caxton Associates LP Acquires 131,589 Shares of Entegris, Inc. (NASDAQ:ENTG) - Defense World
2 Kite vets fly over to Kyverna Therapeutics—Chutes & Ladders - Fierce Biotech
Nautilus Biotechnology senior VP sells shares worth over $99k - Investing.com India
Nautilus Biotechnology senior VP sells shares worth over $99k By Investing.com - Investing.com Canada
New CEOs at Nura, IMU - BioCentury
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer | Daily - Daily Guardian Canada
Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - GlobeNewswire
Nautilus Biotechnology, Inc.'s (NASDAQ:NAUT) Top Key Executive Parag Mallick is the most upbeat insider, and their holdings increased by 11% last week - Simply Wall St
Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Down 0.8% - MarketBeat
Who Is Jeff Bezos: History, Background, Achievements, and Net Worth - Investing.com
Dr. Parag Mallick, PhDCo-Founder, Nautilus BiotechnologyUnlocking The Complexity Of The Proteome For A New Era Of Scientific Discovery - Audacy
Nautilus Biotechnology Insider Ups Holding During Year - Yahoo Finance
XPeng Inc. (NYSE:XPEV) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Vanguard Group Inc. Acquires 29,604 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World
Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - StockTitan
Nautilus Biotechnology (NASDAQ:NAUT) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2024 Earnings Call Transcript - Insider Monkey
Nautilus Biotechnology, Inc. (NAUT) Q2 2024 Earnings Call Transcript - Seeking Alpha
NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q2 2024 - InvestorPlace
Nautilus Down on Releasing Q2 Numbers - Baystreet.ca
Nautilus Biotechnology Reports Second Quarter 2024 Financial Results - GlobeNewswire
Nautilus Biotechnology Inc (NAUT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):